Log In
Print this Print this

Intranasal naloxone

Also known as: Naloxone nasal spray

  Manage Alerts
Collapse Summary General Information
Company Lightlake Therapeutics Inc.
DescriptionOpioid antagonist nasal spray
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAddiction
Indication DetailsReverse opioid overdose; Treat and prevent binge eating disorder; Treat binge eating disorder; Treat binge eating disorder in overweight and obese patients; Treat bulimia nervosa; Treat opioid addiction; Treat overeating in patients with premenstrual syndrome (PMS)
Regulatory Designation

U.S. - Fast Track (Reverse opioid overdose)


Adapt Pharma Ltd.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today